Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Reduced humoral immune response after mRNA vaccination correlates with breakthrough SARS-CoV-2 infection in ocrelizumab-treated multiple sclerosis patients

Author:Novak, Frederik   Bajwa, Hamza   Eugenio Coia, John   Nilsson, Anna Christine   Nielsen, Christian   Holm, Dorte   Østergaard, Kamilla   Hvidt, Mathilde   Byg, Keld-Erik   Johansen, Isik   Mittl, Kristen   Rowles, William   Zamvil, Scott   Bove, Riley   Sabatino, Joseph   Sejbaek, Tobias   

Session Name:P12: MS COVID and Clinical Practice  

Topic:MS and Inflammatory Disease  

Program Number:P12.005  

Author Institution:Southwest Jutland Hospital, Esbjerg, Denmark  University of Southern Denmark, Odense, Denmark  Odense University Hospital, Odense, Denmark  Nordsjællands Hospital, Hillerød, Denmark  Hospitalsenhed Midt, Viborg, Denmark  UCSF, San Francisco, CA  University of CA, San Francisco, San Francisco, CA  University of California, San Francisco, Berkeley, CA  University of California San Francisco, San Francisco, CA  

Characterizing the Patient Experience During the Prodrome Phase of Migraine: A Qualitative Study of Symptoms and Their Timing

Author:Stokes, Jonathan   Lipton, Richard B.   Evans, Christopher   Hribal, Elizabeth   White, Kailee   Keyloun, Katelyn   Parikh, Krutika   Gandhi, Pranav   Dodick, David W.   

Session Name:P7: Headache: Clinical Investigations in Headache 2  

Topic:Headache  

Program Number:P7.002  

Author Institution:AbbVie, Madison, NJ  Albert Einstein College of Medicine, Bronx, NY  Endpoint Outcomes, Boston, MA  Endpoint Outcomes, Long Beach, CA  AbbVie, North Chicago, IL  Mayo Clinic, Phoenix, AZ  

LACE+ is marginally predictive of 30-day readmission after stroke

Author:Khan, Muhib   Hildreth, Freddie   Haggerty, Diana   Knight, Jay   Miller, Malgorzata   Tsai, Jenny   Scott, Victoria   Tubergen, Tricia   Evans, Elizabeth   Khan, Nadeem   Wees, Nabil   Ahrar, Asad   Min, Jiangyong   DeJesus Brazitis, Michelle   Packard, Laurel   

Session Name:P11: Cerebrovascular Disease and Interventional Neurology: Neuroimaging and Secondary Stroke Prevention  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P11.027  

Author Institution:Michigan State University , Grand Rapids, MI  Spectrum Health, Grand Rapids, MI  Michigan State University , Flint, MI  Spectrum Health West Michigan, Grand Rapids, MI  Spectrum Health , Grand Rapids, MI  Spectrum Health Medical Group, Grand Rapids, MI  Spectrum Health Neuroscience, Grand Rapids, MI  

Patient Characteristics and Persistence Among Commercially Insured Patients With Multiple Sclerosis Initiating Cladribine Tablets

Author:Kozma, Chris   Evans, Emily   Lebson, Lori   Phillips, Amy   Lobo, Carroline   

Session Name:P14: MS Clinical Practice  

Topic:MS and Inflammatory Disease  

Program Number:P14.001  

Author Institution:CK Consulting Associates, LLC, West Columbia, SC  EMD Serono, Inc., Rockland, MA  EMD Serono, Inc., Chattanooga, TN  EMD Serono Inc. - Rockland, MA, Rockland, MA  

An Iatrogenic Cause of Proximal Tibial Mononeuropathy Resulting in Undiagnosed Foot Pain

Author:Priaulx, Austin   Evans, John   

Session Name:P9: Pain: Case Series and Case Reports  

Topic:Pain  

Program Number:P9.008  

Author Institution:Philadelphia College of Osteopathic Medicine , Jacksonville, FL  Mayo Clinic, Jacksonville, FL